Healthcare provider profile · identity verified

James W Morris, MD

Family Practice · AUGUSTA, KY · NPI 1255324471

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	169	36
Gabapentin	Gabapentin	132	20
Metformin Hcl	Metformin Hcl	127	25
Amlodipine Besylate	Amlodipine Besylate	118	29
Alprazolam	Alprazolam	104	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	102	27
Simvastatin	Simvastatin	100	23
Lisinopril	Lisinopril	97	22
Levothyroxine Sodium	Levothyroxine Sodium	96	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	88	31
Tramadol Hcl	Tramadol Hcl	83	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	82	19
Lorazepam	Lorazepam	82	15
Fenofibrate	Fenofibrate	78	14
Tamsulosin Hcl	Tamsulosin Hcl	76	14
Furosemide	Furosemide	73	17
Prednisone	Prednisone	57	31
Carvedilol	Carvedilol	55	13
Losartan Potassium	Losartan Potassium	54	13
Potassium Chloride	Potassium Chloride	51	12
Diazepam	Diazepam	48	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	48	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Meloxicam	Meloxicam	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Sertraline Hcl	Sertraline Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	16
Atenolol	Atenolol	31	suppressed
Glipizide	Glipizide	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Cephalexin	Cephalexin	24	20
Cyproheptadine Hcl	Cyproheptadine Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	18
Ibuprofen	Ibuprofen	24	suppressed
Metoprolol Succinate	Metoprolol Succinate	24	suppressed
Theophylline Er	Theophylline Anhydrous	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Xarelto	Rivaroxaban	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Eliquis	Apixaban	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Allopurinol	Allopurinol	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error